Company Akoya Biosciences, Inc.

Equities

AKYA

US00974H1041

Advanced Medical Equipment & Technology

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Ratings for Akoya Biosciences, Inc.

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-18 pm EDT			5-day change	1st Jan Change
3.85 ^USD	-1.53%		-10.47%	-21.11%

Apr. 05	Akoya Biosciences Showcases Spatial Biology 2.0 Solutions At AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale	CI
Mar. 06	JPMorgan Adjusts Price Target on Akoya Biosciences to $10 From $12, Maintains Overweight Rating	MT

Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery, clinical research, and diagnostics. It offers single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. It offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research: PhenoCode Panels and PhenoCycler, PhenoImager Fusion and PhenoImager HT Instruments. Its PhenoCycler platform provides ultra-high parameter biomarker discovery, with the ability to analyze high-plex single-cell resolution across the entire tissue sample. Its PhenoImager platform enables researchers to visualize, analyze, quantify and phenotype cells in situ, in fresh frozen or formalin-fixed paraffin-embedded (FFPE) tissue sections, and tissue microarrays (TMAs).

Number of employees: 330

USD in Million	2022	Weight	2023	Weight	Delta
Instruments 43.6 %	39	51.6 %	42	43.6 %	+8.96%
Service and Other 30.2 %	17	23.0 %	29	30.2 %	+69.81%
Consumables 25.0 %	18	24.6 %	24	25.0 %	+31.31%
Standalone Software 1.2 %	1	0.8 %	1	1.2 %	+85.69%

USD in Million	2022	Weight	2023	Weight	Delta
North America 60.3 %	42	56.2 %	58	60.3 %	+38.62%
EMEA 22.6 %	18	23.7 %	22	22.6 %	+22.76%
APAC 17.1 %	15	20.1 %	17	17.1 %	+9.93%

Managers	Title	Age	Since
Brian McKelligon CEO	Chief Executive Officer	55	17-06-30
Johnny Ek DFI	Director of Finance/CFO	48	23-03-19
Pascal Bamford CTO	Chief Tech/Sci/R&D Officer	-	21-10-25
Frederic Pla COO	Chief Operating Officer	65	21-03-30
Peter J. Miller CTO	Chief Tech/Sci/R&D Officer	-	18-09-30
Priyam Shah IRC	Investor Relations Contact	-	-
Jennifer Kamocsay LAW	General Counsel	53	23-02-27
Gavin Gordon PRN	Corporate Officer/Principal	-	20-06-30
Elliot Shelton		-	-
Niro Ramachandran PRN	Corporate Officer/Principal	49	20-07-31

Members of the board	Title	Age	Since
Robert Shepler CHM	Chairman	67	15-10-31
Myla Lai-Goldman BRD	Director/Board Member	66	21-09-15
Thomas Schnettler BRD	Director/Board Member	67	19-08-31
Matthew Winkler BRD	Director/Board Member	71	17-06-30
Thomas Raffin BRD	Director/Board Member	77	15-10-31
Brian McKelligon CEO	Chief Executive Officer	55	17-06-30
Scott Mendel BRD	Director/Board Member	57	21-06-10

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	49,140,731	25,140,336 ( 51.16 %)	0	51.16 %

Name	Equities	%	Valuation
Telegraph Hill Partners Management Co. LLC 35.97 %	17,675,247	35.97 %	83 M $
Blue Water Life Science Advisors LP 9.560 %	4,697,785	9.560 %	22 M $
PSC Capital Partners LLC 7.158 %	3,517,360	7.158 %	16 M $
aMoon Ventures Y Sh Ltd. 6.262 %	3,077,195	6.262 %	14 M $
POLAR CAPITAL HOLDINGS PLC 3.215 %	1,579,756	3.215 %	7 M $
Vanguard Fiduciary Trust Co. 2.866 %	1,408,157	2.866 %	7 M $
BlackRock Advisors LLC 2.683 %	1,318,497	2.683 %	6 M $
Matthew Winkler 2.003 %	984,513	2.003 %	5 M $
Parkman Healthcare Partners LLC 1.373 %	674,787	1.373 %	3 M $
Uniplan Investment Counsel, Inc. 1.371 %	673,523	1.371 %	3 M $

Akoya Biosciences, Inc.

100 Campus Drive 6th Floor

01752, Marlborough

http://www.akoyabio.com

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

3.85 USD

Average target price

9 USD

Spread / Average Target

+133.77%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Advanced Medical Equipment & Technology

Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
AKOYA BIOSCIENCES, INC.	-21.11%	189M
THERMO FISHER SCIENTIFIC	+2.02%	207B
DANAHER CORPORATION	+2.17%	175B
INTUITIVE SURGICAL, INC.	+10.45%	132B
BOSTON SCIENTIFIC CORPORATION	+16.62%	99.1B
SIEMENS HEALTHINEERS AG	-2.70%	60.89B
EDWARDS LIFESCIENCES CORPORATION	+13.38%	52.04B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-6.33%	45.48B
AGILENT TECHNOLOGIES, INC.	-4.74%	38.81B
GE HEALTHCARE TECHNOLOGIES INC.	+9.89%	38.77B

Other Advanced Medical Equipment & Technology